PCCS Group Bhd Cash Flow Conversion Efficiency
PCCS Group Bhd cash flow conversion efficiency. Based on the latest financial reports, PCCS Group Bhd (6068) has a cash flow conversion efficiency ratio of 0.196x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM34.61 Million ≈ $8.69 Million USD) by net assets (RM176.33 Million ≈ $44.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is PCCS Group Bhd worth for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of PCCS Group Bhd (2013–2025)
Cash flow conversion efficiency of PCCS Group Bhd from 2013 to 2025. This chart illustrates how PCCS Group Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View PCCS Group Bhd stock price for real-time trading data and today's change.
PCCS Group Bhd Cash Flow Conversion Ratio Explained
PCCS Group Bhd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
PCCS Group Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PCCS Group Bhd ranked by their cash flow conversion efficiency. Review PCCS Group Bhd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Powerhouse Ventures Ltd
AU:PVL
|
-0.030x |
|
Loyal Lithium Ltd.
AU:LLI
|
0.010x |
|
Earlyworks Co., Ltd. American Depositary Shares
NASDAQ:ELWS
|
-1.245x |
|
CHEMOMAB THERAP. ADR/20
F:2QV0
|
N/A |
|
PT Cahayasakti Investindo Sukses Tbk
JK:CSIS
|
0.018x |
|
NEP Realty and Industry Public Company Limited
BK:NEP
|
-0.011x |
|
Rubberex Corporation M Bhd
KLSE:7803
|
-0.008x |
|
Madhav Copper Limited
NSE:MCL
|
0.168x |
Annual Cash Flow Conversion Efficiency for PCCS Group Bhd (2013–2025)
The table below shows the annual cash flow conversion efficiency of PCCS Group Bhd from 2013 to 2025. Also see total assets of PCCS Group Bhd for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | RM171.46 Million ≈ $43.05 Million |
RM17.65 Million ≈ $4.43 Million |
0.103x | +140.71% |
| 2024-03-31 | RM171.59 Million ≈ $43.08 Million |
RM-43.39 Million ≈ $-10.89 Million |
-0.253x | -486.34% |
| 2023-03-31 | RM167.41 Million ≈ $42.03 Million |
RM10.96 Million ≈ $2.75 Million |
0.065x | +177.18% |
| 2022-03-31 | RM163.97 Million ≈ $41.17 Million |
RM-13.91 Million ≈ $-3.49 Million |
-0.085x | -337.47% |
| 2021-03-31 | RM160.17 Million ≈ $40.21 Million |
RM-3.10 Million ≈ $-779.56K |
-0.019x | -110.33% |
| 2020-03-31 | RM153.51 Million ≈ $38.54 Million |
RM28.82 Million ≈ $7.24 Million |
0.188x | -13.44% |
| 2019-03-31 | RM140.34 Million ≈ $35.23 Million |
RM30.43 Million ≈ $7.64 Million |
0.217x | +23.05% |
| 2018-03-31 | RM125.21 Million ≈ $31.44 Million |
RM22.07 Million ≈ $5.54 Million |
0.176x | +676.67% |
| 2017-03-31 | RM86.51 Million ≈ $21.72 Million |
RM-2.64 Million ≈ $-663.82K |
-0.031x | -19.19% |
| 2016-03-31 | RM96.91 Million ≈ $24.33 Million |
RM-2.48 Million ≈ $-623.90K |
-0.026x | -235.90% |
| 2015-03-31 | RM106.00 Million ≈ $26.61 Million |
RM2.00 Million ≈ $502.13K |
0.019x | -89.13% |
| 2014-03-31 | RM121.00 Million ≈ $30.38 Million |
RM21.00 Million ≈ $5.27 Million |
0.174x | +3.22% |
| 2013-03-31 | RM113.00 Million ≈ $28.37 Million |
RM19.00 Million ≈ $4.77 Million |
0.168x | -- |
About PCCS Group Bhd
PCCS Group Berhad, an investment holding company, primarily manufactures, markets, and sells apparel in Malaysia, Cambodia, Hong Kong, Singapore, and the People's Republic of China. It operates in four segments: Apparel, Label and Packaging, Credit Financing, and Others. The company also engages in the research and development, manufacturing, import, and export of medical and healthcare products;… Read more